Pamicell Signs Nucleotide Supply Contract Worth 600 Million KRW
[Asia Economy Reporter Geum Bo-ryeong] Pharmicell announced on the 18th that it has signed a supply contract worth 556 million KRW for pharmaceutical intermediate nucleosides with Sigma-Aldrich.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
The contract amount corresponds to 1.71% of sales as of the end of last year. The contract period is until June 28 of next year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
